Kerri-Ann Millar
2023
In 2023, Kerri-Ann Millar earned a total compensation of $1.2M as Chief Financial Officer at Cue Biopharma, a 10% increase compared to previous year.
Compensation breakdown
| Option Awards | $715,201 |
|---|---|
| Salary | $444,181 |
| Other | $3,156 |
| Total | $1,162,538 |
Millar received $715.2K in option awards, accounting for 62% of the total pay in 2023.
Millar also received $444.2K in salary and $3.2K in other compensation.
Rankings
In 2023, Kerri-Ann Millar's compensation ranked 1,032nd out of 2,878 executives tracked by ExecPay. In other words, Millar earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,032 out of 2,878 | 64th |
Division Manufacturing | 617 out of 1,582 | 61st |
Major group Chemicals And Allied Products | 425 out of 891 | 52nd |
Industry group Drugs | 414 out of 854 | 52nd |
Industry Pharmaceutical Preparations | 282 out of 614 | 54th |
Source: SEC filing on April 26, 2024.
Millar's colleagues
We found two more compensation records of executives who worked with Kerri-Ann Millar at Cue Biopharma in 2023.